Expanded Access Program With Lanadelumab for Japanese People With Hereditary Angioedema

Clinical trial NCT04687137 · COMPLETED

Trial details

NCT number: NCT04687137
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema

Start date: 2021-02-10
Primary completion: 2022-06-18
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.